Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE:002287)
China flag China · Delayed Price · Currency is CNY
20.98
+0.08 (0.38%)
Jul 31, 2026, 3:04 PM CST

SHE:002287 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
2,4182,4162,3382,0452,0451,770
Revenue Growth
1.78%3.34%14.32%0.02%15.49%19.22%
Gross Profit
2,0172,0051,9181,7201,7191,501
Operating Income
597.07603.98536.7467.52527.71416.45
Net Income
667.92648.43582.28581.2472.54715.88
Earnings Per Share
1.211.191.101.100.891.35
EPS Growth
14.46%8.64%0.15%23.05%-34.13%77.01%

Revenue by Segment

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Medicine
2,4012,3182,0262,0311,756
Others
14.9819.719.614.2214.16
Total
2,4162,3382,0452,0451,770

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
2,6553,0402,9972,3662,2021,958
Total Debt
807.83929.841,6981,5351,6971,452
Net Cash (Debt)
1,8472,1101,299831.28504.82506.11
Net Cash Growth
33.02%62.46%56.24%64.67%-0.26%-18.75%
Net Cash Per Share
3.343.882.451.570.950.96

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
310.41729.7456.75693.41285.691,035
Capital Expenditures
-125.06-153.08-255.44-234.81-272.4-125.57
Free Cash Flow
185.35576.63201.31458.5913.29909.35
Free Cash Flow Growth
-71.37%186.44%-56.10%3350.89%-98.54%-

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
83.40%83.00%82.06%84.12%84.08%84.77%
Operating Margin
24.69%25.00%22.96%22.86%25.81%23.52%
Pretax Margin
31.42%30.62%27.64%31.51%25.39%44.50%
Profit Margin
27.62%26.84%24.91%28.42%23.11%40.43%
FCF Margin
7.66%23.87%8.61%22.42%0.65%51.36%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.3800.4100.3800.4800.3900.590
Dividend Per Share Growth
5.00%7.90%-20.83%23.08%-33.90%73.53%
Dividend Yield
1.81%1.77%1.88%2.31%1.88%2.18%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
17.3520.7819.4920.5225.5222.54
Forward PE
-43.5143.5143.5143.5143.51
P/FCF Ratio
64.1723.3756.3626.00907.6017.74
PS Ratio
4.925.584.855.835.909.11